Archives

  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2018-07
  • Leucovorin Calcium: Folate Analog for Methotrexate Rescue...

    2025-12-17

    Leucovorin Calcium: Folate Analog for Methotrexate Rescue in Cancer Research

    Executive Summary: Leucovorin Calcium (calcium folinate) is a water-soluble folic acid derivative (C20H31CaN7O12, MW 601.58) with >98% purity (APExBIO) and validated stability at -20°C for laboratory use (APExBIO product page). It is insoluble in DMSO and ethanol but dissolves in water at ≥15.04 mg/mL with gentle warming. Leucovorin Calcium protects human lymphoid cell lines from methotrexate-induced growth suppression by replenishing reduced folate pools, a mechanism essential for antifolate drug resistance and cell proliferation assays (Shapira-Netanelov et al., 2025). Its deployment in assembloid and organoid models advances preclinical cancer research, underlining its strategic role in dissecting tumor–stroma interactions and optimizing combination therapies.

    Biological Rationale

    Leucovorin Calcium is a chemically stable folate analog used to bypass metabolic blockades imposed by antifolate drugs, such as methotrexate. Methotrexate inhibits dihydrofolate reductase, leading to depletion of reduced folate pools needed for nucleotide synthesis. Leucovorin Calcium restores these pools, thereby rescuing healthy cells from cytotoxic effects while maintaining selective pressure on tumor cells (Shapira-Netanelov et al., 2025). This dual function makes it a critical adjunct in cancer chemotherapy and antifolate drug resistance research.

    Mechanism of Action of Leucovorin Calcium

    Leucovorin Calcium (calcium folinate) does not require reduction by dihydrofolate reductase and can directly participate in folate metabolism. It is converted to tetrahydrofolate derivatives, allowing cells to bypass the blockade induced by antifolates. In the context of methotrexate toxicity, leucovorin enables the synthesis of purines and thymidylate for DNA replication and repair. This mechanism is particularly effective in models where selective protection of non-tumor cells is required for accurate drug assessment (APExBIO).

    Evidence & Benchmarks

    • Leucovorin Calcium at ≥15.04 mg/mL in water (gentle warming, pH 7.0–7.5) demonstrates complete solubility for cell-based assays (APExBIO).
    • In human lymphoid cell lines (LAZ-007, RAJI), Leucovorin Calcium rescues cells from methotrexate-induced cytotoxicity, as measured by cell proliferation and viability assays (Shapira-Netanelov et al., 2025).
    • Patient-derived gastric cancer assembloids integrating stromal subpopulations show altered drug response profiles and increased physiological relevance when Leucovorin Calcium is used as a rescue agent (Shapira-Netanelov et al., 2025).
    • Leucovorin Calcium enhances the predictive power of personalized chemotherapy adjunct protocols in advanced tumor models (Related article).
    • The compound maintains ≥98% purity under -20°C storage, ensuring batch-to-batch reproducibility for scientific research (APExBIO).

    Applications, Limits & Misconceptions

    Leucovorin Calcium is indispensable for:

    • Protection from methotrexate-induced growth suppression in cancer cell lines and assembloids.
    • Investigating folate metabolism pathways and antifolate drug resistance mechanisms.
    • Optimizing chemotherapy adjunct strategies in translational cancer research (Mechanistic guide—this article extends the mechanistic focus with practical integration benchmarks).
    • Personalized drug screening using assembloid models, especially where stromal–tumor interactions are probed (See also—our article provides fresh quantitative benchmarks for model selection).

    Common Pitfalls or Misconceptions

    • Leucovorin Calcium is not suitable for direct clinical or diagnostic use; it is strictly for research applications.
    • It cannot reverse methotrexate effects in all cell types; efficacy depends on the presence of functional folate pathways.
    • Long-term storage in solution form leads to significant degradation; only short-term aqueous use is recommended.
    • It does not substitute for all folate derivatives; its rescue effect is specific to antifolate-induced cytotoxicity, not general folate deficiency.
    • Improper pH or solvent selection (e.g., DMSO, ethanol) results in precipitation or inactivation.

    Workflow Integration & Parameters

    For laboratory workflows, Leucovorin Calcium (SKU: A2489) is recommended to be dissolved in water at concentrations up to 15.04 mg/mL with gentle warming and neutral pH (7.0–7.5). Store lyophilized powder at -20°C and reconstitute immediately before use. Avoid repeated freeze-thaw cycles. In cell proliferation assays, typical concentrations range from 10 nM to 1 mM depending on model sensitivity (APExBIO). Integration into assembloid systems requires careful titration to avoid masking antifolate efficacy. For comprehensive methodological guidance, see our extended review on workflow strategies (Advancing Methotrexate Rescue—this article provides updated workflow parameters in the context of stromal–tumor model systems).

    Conclusion & Outlook

    Leucovorin Calcium is essential for dissecting folate metabolism and antifolate drug resistance in preclinical cancer research. Its robust solubility profile, high purity, and mechanistic specificity make it a gold standard for methotrexate rescue protocols. The integration of Leucovorin Calcium in advanced assembloid models, as shown by recent studies, highlights its value for personalized drug screening and the development of more effective chemotherapy adjuncts (Shapira-Netanelov et al., 2025). For detailed product specs and ordering, visit the APExBIO Leucovorin Calcium page.